Total parenteral nutrition (TPN) is a vital feeding technique for individuals who cannot tolerate oral nutrition. The anabolic response to TPN is often suboptimal due to alterations in the nutritional-hormonal regulation of growth and metabolism. Insulin-like growth factor I (IGF-I) mediates the actions of growth hormone (GH), causes glucose uptake, and is anabolic in the gut and immune system. IGF-I production and action are regulated by nutritional, hormonal, and metabolic status. The long term goal of this research is to understand the mechanisms by which the nutrient composition of TPN and the GH/IGF-I system interact to design TPN protocols, i.e., combinations of nutrients and growth factors, that will optimize tissue repair and growth. The four specific aims are to determine: 1)the dose-response relationship for the anabolic effects of IGF-I, GH and the combination of these growth factors when given concurrently with TPN; 2)if increased body growth due to administration of IGF-I plus GH during TPN is secondary to increased protein synthesis and increased carbohydrate oxidation; 3)the relationship between parenteral fat emulsions, gut immune function and the known ability of IGF-I to attenuate TPN-induced gut atrophy; and 4)how the nonprotein source of parenteral energy glucose vs. fat) and the total amount of parenteral energy regulate hepatic IGF-I synthesis, and the anabolic response to exogenous IGF-I and its analogues that do not bind IGF binding proteins. TPN feeding studies will be conducted in rats given surgical stress or dexamethasone treatment; IGF-I will be confused with the TPN solution. IGF-I system responses will be assessed by determining: serum concentrations of GH, IGF-I, IGF binding proteins, insulin, and glucose; tissue abundance of mRNAs for IGF-I, IGF-I and GH receptors, and IGF binding proteins; and by conducting receptor binding and tyrosine kinase studies. Anabolic response will be assessed by determining body weight and composition, nitrogen balance, the fractional rate of protein synthesis and energy expenditure.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Nutrition Study Section (NTN)
Program Officer
May, Michael K
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Wisconsin Madison
Schools of Earth Sciences/Natur
United States
Zip Code
Sangild, Per T; Ney, Denise M; Sigalet, David L et al. (2014) Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges. Am J Physiol Gastrointest Liver Physiol 307:G1147-68
Murali, Sangita G; Brinkman, Adam S; Solverson, Patrick et al. (2012) Exogenous GLP-2 and IGF-I induce a differential intestinal response in IGF binding protein-3 and -5 double knockout mice. Am J Physiol Gastrointest Liver Physiol 302:G794-804
Brinkman, Adam S; Murali, Sangita G; Hitt, Stacy et al. (2012) Enteral nutrients potentiate glucagon-like peptide-2 action and reduce dependence on parenteral nutrition in a rat model of human intestinal failure. Am J Physiol Gastrointest Liver Physiol 303:G610-22
Baumler, Megan D; Koopmann, Matthew C; Thomas, Diana D H et al. (2010) Intravenous or luminal amino acids are insufficient to maintain pancreatic growth and digestive enzyme expression in the absence of intact dietary protein. Am J Physiol Gastrointest Liver Physiol 299:G338-47
Koopmann, Matthew C; Chen, Xueyan; Holst, Jens J et al. (2010) Sustained glucagon-like peptide-2 infusion is required for intestinal adaptation, and cessation reverses increased cellularity in rats with intestinal failure. Am J Physiol Gastrointest Liver Physiol 299:G1222-30
Koopmann, Matthew C; Baumler, Megan D; Boehler, Christopher J et al. (2010) Total parenteral nutrition attenuates cerulein-induced pancreatitis in rats. Pancreas 39:377-84
Liu, Xiaowen; Murali, Sangita G; Holst, Jens J et al. (2009) Whey protein potentiates the intestinotrophic action of glucagon-like peptide-2 in parenterally fed rats. Am J Physiol Regul Integr Comp Physiol 297:R1554-62
Koopmann, Matthew C; Liu, Xiaowen; Boehler, Christopher J et al. (2009) Colonic GLP-2 is not sufficient to promote jejunal adaptation in a PN-dependent rat model of human short bowel syndrome. JPEN J Parenter Enteral Nutr 33:629-38; discussion 638-9
Koopmann, Matthew C; Nelson, David W; Murali, Sangita G et al. (2008) Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats. JPEN J Parenter Enteral Nutr 32:254-65
Liu, Xiaowen; Murali, Sangita G; Holst, Jens J et al. (2008) Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats. Am J Physiol Regul Integr Comp Physiol 295:R1794-802

Showing the most recent 10 out of 39 publications